+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Therapeutics Market by Therapeutic Area (Cancer Therapies, Contraceptives, Gynecological Disorders), Product Type (Biologics, Devices, Drugs), Distribution Channel, End-User - Global Forecast 2025-2030- Product Image
Women's Health Therapeutics Market by Therapeutic Area (Cancer Therapies, Contraceptives, Gynecological Disorders), Product Type (Biologics, Devices, Drugs), Distribution Channel, End-User - Global Forecast 2025-2030- Product Image
Sale

Women's Health Therapeutics Market by Therapeutic Area (Cancer Therapies, Contraceptives, Gynecological Disorders), Product Type (Biologics, Devices, Drugs), Distribution Channel, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666342
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The women's health therapeutics market is experiencing rapid transformation driven by advances in precision medicine, expanding digital solutions, and a push for patient-centric and inclusive care models. As global healthcare systems refocus on tailored treatments for women’s unique needs, key players are realigning their strategies to capture growth, ensure access, and support patient outcomes.

Market Snapshot: Women’s Health Therapeutics Market Overview

The Women's Health Therapeutics Market grew from USD 72.21 billion in 2024 to USD 80.11 billion in 2025. It is expected to continue growing at a CAGR of 10.84%, reaching USD 133.97 billion by 2030. This growth reflects strong demand for specialized therapies, evolving regulatory structures, and ongoing innovation in clinical care frameworks. Market expansion is being shaped by stakeholder collaboration, adoption of novel drug modalities, and increased regulatory recognition of women’s health as a critical priority. Senior decision-makers are responding to shifts in patient engagement and data-driven digital tools, which are fostering market agility and remote management opportunities.

Scope & Segmentation

  • Therapeutic Areas: Includes cancer therapies (breast, cervical, endometrial, and ovarian), contraceptives (barrier, implant, injectable, IUD, pill, sterilization), gynecological disorders (endometriosis, pelvic inflammatory disease, polycystic ovary syndrome, uterine fibroids), menopausal therapies (botanical supplements, hormone replacement therapies such as estrogen, estrogen plus progestin, tibolone, and nonhormonal alternatives), and osteoporosis treatments (bisphosphonates, denosumab, parathyroid hormone analogues, selective estrogen receptor modulators).
  • Product Types: Biologics (monoclonal antibodies, recombinant proteins, vaccines), diagnostic, monitoring, and therapeutic devices, along with branded and generic drugs.
  • Distribution Channels: Drug stores, hospital pharmacies, online platforms, and retail pharmacies.
  • End-User Segments: Clinics, hospitals, homecare environments, and specialty centers.
  • Regions Covered: Americas (including the US, Canada, Mexico, Brazil, Argentina), Europe, Middle East, & Africa (key markets include United Kingdom, Germany, France, Russia, Italy, Spain, South Africa), and Asia-Pacific (with China, India, Japan, Australia, South Korea, as well as ASEAN countries).
  • Key Companies Tracked: Bayer AG, Johnson & Johnson, Ferring B.V., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Merck & Co., Inc., AbbVie Inc., Amgen Inc., Novo Nordisk A/S, Gedeon Richter Plc.

Key Takeaways for Decision-Makers

  • Innovation is driving a shift from conventional contraceptive and supplement approaches to advanced biologics, precision oncology, and digital therapeutics, broadening both treatment impact and commercial opportunity.
  • Patient-centric models and digital health platforms are enhancing engagement, adherence, and long-term management of chronic gynecological and menopausal conditions, ensuring continuity of care across diverse settings.
  • Collaborative research pipelines are leveraging artificial intelligence and real-world evidence to streamline development and regulatory pathways, accelerating the availability of differentiated therapies.
  • Value-based care agreements and outcome-focused strategies are prompting manufacturers, payers, and providers to emphasize long-term benefits and cost optimization for sustainable growth.
  • Regional dynamics reflect varying maturity in reimbursement, infrastructure, and technology adoption, requiring tailored go-to-market approaches, especially in emerging markets with evolving access challenges.

Tariff Impact: Addressing US Trade Levies in 2025

The introduction of United States tariffs in 2025 has altered supply chain and sourcing strategies for women's health therapeutics. Companies are shifting suppliers, investing in nearshoring, and implementing cost management tactics to protect margins and ensure continuity of essential therapies. These adjustments are affecting inventory management and patient access programs, leading to redesigned affordability initiatives and strengthened supply chain resilience.

Methodology & Data Sources

This market assessment uses qualitative and quantitative research, including secondary data from health databases and regulatory filings, and primary inputs from industry leaders. Triangulation and advanced statistical techniques validate all insights, with robust scenario analysis of policy shifts and peer review controls for accuracy.

Why This Report Matters

  • Supports strategic planning and investment by enabling clear identification of high-growth segments and technology trends.
  • Guides risk mitigation, cost optimization, and supply continuity strategies in evolving global contexts, including regulatory and tariff disruptions.
  • Equips senior leaders with actionable segmentation and regional insights to drive informed market entry and resource allocation decisions.

Conclusion

The women’s health therapeutics market is evolving through innovation, collaboration, and a clear focus on patient outcomes. With informed strategies, industry leaders can capture emerging opportunities and foster meaningful impact on women’s health worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of digital therapeutics integrating AI-driven personalized hormone management
5.2. Expansion of telehealth platforms offering remote monitoring and adherence support for menopausal care
5.3. Increasing investment in next-generation non-hormonal contraceptives targeting novel molecular pathways
5.4. Growth of fertility preservation services leveraging precision medicine and advanced cryopreservation
5.5. Emergence of microbiome-based therapies for endometriosis and PCOS symptom management
5.6. Rising demand for mobile health applications combining mental health support with menstrual tracking
5.7. Development of implantable drug delivery systems for sustained release of osteoporosis treatments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Women's Health Therapeutics Market, by Therapeutic Area
8.1. Introduction
8.2. Cancer Therapies
8.2.1. Breast Cancer
8.2.1.1. Her2 Positive
8.2.1.2. Hormone Receptor Positive
8.2.1.3. Triple Negative
8.2.2. Cervical Cancer
8.2.3. Endometrial Cancer
8.2.4. Ovarian Cancer
8.3. Contraceptives
8.3.1. Barrier Methods
8.3.2. Implant
8.3.3. Injectable
8.3.4. Iud
8.3.5. Pill
8.3.6. Sterilization
8.4. Gynecological Disorders
8.4.1. Endometriosis
8.4.2. Pelvic Inflammatory Disease
8.4.3. Polycystic Ovary Syndrome
8.4.4. Uterine Fibroids
8.5. Menopausal Therapies
8.5.1. Botanical Supplements
8.5.2. Hormone Replacement Therapy
8.5.2.1. Estrogen
8.5.2.2. Estrogen Plus Progestin
8.5.2.3. Tibolone
8.5.3. Nonhormonal Therapies
8.6. Osteoporosis
8.6.1. Bisphosphonates
8.6.2. Denosumab
8.6.3. Pth Analogues
8.6.4. Serms
9. Women's Health Therapeutics Market, by Product Type
9.1. Introduction
9.2. Biologics
9.2.1. Monoclonal Antibodies
9.2.2. Recombinant Proteins
9.2.3. Vaccines
9.3. Devices
9.3.1. Diagnostic Devices
9.3.2. Monitoring Devices
9.3.3. Therapeutic Devices
9.4. Drugs
9.4.1. Branded
9.4.2. Generic
10. Women's Health Therapeutics Market, by Distribution Channel
10.1. Introduction
10.2. Drug Stores
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.5. Retail Pharmacy
11. Women's Health Therapeutics Market, by End-User
11.1. Introduction
11.2. Clinics
11.3. Homecare
11.4. Hospitals
11.5. Specialty Centers
12. Americas Women's Health Therapeutics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Women's Health Therapeutics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Women's Health Therapeutics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Johnson & Johnson
15.3.3. Ferring B.V.
15.3.4. Teva Pharmaceutical Industries Ltd.
15.3.5. Pfizer Inc.
15.3.6. Merck & Co., Inc.
15.3.7. AbbVie Inc.
15.3.8. Amgen Inc.
15.3.9. Novo Nordisk A/S
15.3.10. Gedeon Richter Plc
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. WOMEN'S HEALTH THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. WOMEN'S HEALTH THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. WOMEN'S HEALTH THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. WOMEN'S HEALTH THERAPEUTICS MARKET: RESEARCHAI
FIGURE 24. WOMEN'S HEALTH THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. WOMEN'S HEALTH THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 26. WOMEN'S HEALTH THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. WOMEN'S HEALTH THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HER2 POSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HER2 POSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE RECEPTOR POSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE RECEPTOR POSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TRIPLE NEGATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TRIPLE NEGATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BARRIER METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BARRIER METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IMPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IMPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PILL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PILL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STERILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PELVIC INFLAMMATORY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PELVIC INFLAMMATORY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN PLUS PROGESTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN PLUS PROGESTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TIBOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TIBOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY NONHORMONAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY NONHORMONAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BISPHOSPHONATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BISPHOSPHONATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DENOSUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DENOSUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PTH ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PTH ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SERMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SERMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 199. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 200. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 201. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2024 (USD MILLION)
TABLE 202. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2025-2030 (USD MILLION)
TABLE 203. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 204. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 205. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 206. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 207. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 208. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 209. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 210. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 211. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 212. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 213. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 214. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 215. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 218. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 219. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 220. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 221. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 222. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 223. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 226. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 227. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 228. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 229. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 232. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 233. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 234. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 235. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 238. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 239. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 243. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 248. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 249. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Women's Health Therapeutics market report include:
  • Bayer AG
  • Johnson & Johnson
  • Ferring B.V.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Novo Nordisk A/S
  • Gedeon Richter Plc

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 80.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 133.97 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Women's Health Therapeutics - Global Strategic Business Report - Product Image

Women's Health Therapeutics - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Gynecology Drugs Market Report 2025 - Product Image

Gynecology Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Gynecology Drugs - Global Strategic Business Report - Product Image

Gynecology Drugs - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Dysmenorrhea Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Drug Class (Hormonal Contraceptives, Nsaids), Route Of Administration, Distribution Channel, Application, End User - Global Forecast 2025-2030 - Product Image

Dysmenorrhea Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Drug Class (Hormonal Contraceptives, Nsaids), Route Of Administration, Distribution Channel, Application, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From

About the Women Health Therapeutic Market

The Women Health Therapeutic market is a subset of the Women's Health industry, focusing on the development and delivery of treatments and therapies for women's health issues. This market includes a range of products and services, from pharmaceuticals and medical devices to lifestyle and wellness products. It also includes services such as health education, counseling, and support. The goal of the Women Health Therapeutic market is to improve the health and well-being of women by providing access to treatments and therapies that are tailored to their needs. Some of the companies in the Women Health Therapeutic market include Pfizer, Merck, Johnson & Johnson, Novartis, Bayer, and GlaxoSmithKline. These companies are involved in the development and delivery of treatments and therapies for women's health issues, as well as providing health education and support services. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.